.png "ONCOSCREEN Logo white and pink (2)")
Bringing Practical tools to patients
Welcome to the Oncoscreen Patient Portal
Empowering You With Knowledge and Tools for Early Colorectal Cancer Detection
Welcome to the Colorectal Cancer Patients’ Portal of ONCOSCREEN — a European research project working to improve how colorectal cancer (CRC) is detected, monitored, and prevented.
Our goal is to help everyone access simple, reliable, and scientifically advanced screening methods — because early detection saves lives.
What ONCOSCREEN Means for You
Colorectal cancer is one of the most common cancers in Europe — but when caught early, it is highly treatable.
ONCOSCREEN aims to make that early detection easier for everyone by developing:
- Non-invasive screening tests using innovative technologies
- Risk-based screening tailored to your age, sex, lifestyle, and health background
- Tools to ensure fair access to screening, especially for communities who may be underserved
Whether you are looking for information, considering screening, or already navigating the process, this portal is designed to guide you.
What You’ll Find Here
What is colorectal cancer
and who is at risk?
When and how should
you get screened?
What are the latest methods being
studied in ONCOSCREEN?
Patient Portal Map
PORTUGAL
BULGARIA
University Specialized Hospital for Active Treatment of Oncology
Contact Person: Dr. Bojidar Tomov
Clinical Trials: ONCO VOC, ONCO NMR, ONCO CRISPR
-------------------------------
Military Medical Academy Sofia
Contact Person: Dr. Daniela Stoyanova
Clinical Trials: ONCO VOC, ONCO NMR, ONCO CRISPR
LITHUANIA
GERMANY
UMC MAINZ
Contact Persons: Markus Moehler ; Katja Petrowski
Clinical Trials: ONCO VOC, NMR, and CRISPR
------------------------------
Lübeck UKSH
Contact Person: Birgitta Spitzner
Clinical Trials: ONCO VOC, NMR, and CRISPR
HUNGARY
University of Szeged
Contact Person: Prof. Dr. Tamás Molnár DSc
Clinical Trials: ONCO NMR and CRISPR
----------------------------
Semmelweis University
Contact Person: Dr. ILIÁS Ákos, PhD
Clinical Trials: ONCO NMR and CRISPR
GREECE
AHEPA University Hospital
Contact Person: Dr. Antonis Billis
Clinical Trials: ONCO VOC, NMR, and CRISPR
ROMANIA
ONCOSCREEN Screening Tools
ONCO-NMR: Employs nuclear magnetic resonance (NMR) spectroscopy to analyze blood serum and plasma, offering a non-invasive diagnostic tool with high specificity and sensitivity.
ONCO CRISPR: Applies CRISPR-Cas9 technology to identify specific genetic biomarkers associated with colorectal cancer, enabling precise detection from minimally invasive samples.
ONCO-VOC: Analyzes volatile organic compounds (VOCs) in exhaled breath using advanced nanomaterial sensors and AI, providing rapid and non-invasive screening results.
ONCO CTC: Utilizes circulating tumor cells (CTCs) in blood samples as a “liquid biopsy” to detect cancer cells that have entered the bloodstream.
Other Tools developed by ONCOSCREEN
ONCO-EVIDA: Evidence-based Decision Analytics dashboard
ONCO-CLIDE: Clinical Decisions Support System for CRC Integrated Diagnosis
ONCO-AITI: AI-Assisted Tissue Image Analysis.
ONCO-CAWA: CRC Awareness Personalised Mobile Application
ONCO-BIOBA: CRC Bio Bank
ONCO-AICO: Real Time AI-Assisted Colonoscopy
ONCO-RISTE: Risk Stratification Engine
CLINICAL TRIALS
An Introduction to Screening Tools
Learn about the new detection methods under evaluation — including simple breath and blood tests and other non-invasive tools — making screening more accessible and patient-friendly.
Patient Stories & Testimonials
Read experiences shared by people who have been screened or diagnosed with CRC. Understanding their journeys can help you feel more confident in your own path.
Opportunities to Participate
If you are eligible and interested, you may have the option to:
- Join pilot studies at participating clinical sites
- Share your feedback as a patient representative
- Contribute to research that will help improve screening for everyone
Participation is always voluntary, and your privacy is always protected.
Empowering All Patients, Across All Communities
CRC doesn’t affect everyone equally. ONCOSCREEN is committed to understanding and addressing barriers to screening — including those related to age, sex, weight, and socio-economic background.
We believe that every person, regardless of where they live or who they are, deserves access to life-saving screening. This portal is part of that mission.
Take the Next Step
Explore our resources, learn more about screening, or connect with local clinical sites participating in ONCOSCREEN.
Newsletter Signup
To keep up-to-date with the latest developments in the ONCOSCREEN project, subscribe to our LinkedIn newsletter.
You can always unsubscribe at a later time if you change your mind.
